Sujuan Ba is the President and CEO of the National Foundation for Cancer Research (NFCR), a nonprofit dedicated to funding high-risk, high-impact cancer research worldwide. She oversees NFCR’s scientific funding, global partnerships, and strategic initiatives, fostering collaboration among researchers across the US, Europe, and Asia. Under her leadership, NFCR has strengthened its role as a global catalyst for translational cancer research, launching the Szent-Györgyi Prize for Progress in Cancer Research and spearheading innovative programs such as the ScreenSaver-LifeSaver Project, which created the world’s largest distributed computing network for drug discovery, accelerating the identification of potential cancer therapies.
Dr. Ba also co-founded the AIM-HI Accelerator Fund and Venture Competition to support early-stage oncology companies, and she helped establish GBM AGILE, a global adaptive platform trial for glioblastoma that accelerates drug evaluation and patient enrollment. She serves as a scientific advisor or board member for multiple oncology startups and has received numerous recognitions, including the 2024 Pioneer in Medicine Award, the Leadership Award for Global Advocate of Cancer Research, and the CRS Women in Sciences Award.
The 100 CEOs featured here reflect the diversity and complexity of modern oncology leadership. In 2025, some lead the world’s largest cancer institutions; others guide specialized societies or emerging innovators. What unites them is responsibility: for millions of patients, for the integrity of science, and for the future direction of cancer care globally.
This list is not a celebration of power, but a recognition of stewardship, accountability, and impact – and of the leaders whose choices continue to shape the fight against cancer. For the many deserving individuals not mentioned in this list, we will continue to acknowledge, honor and elevate your voices in our daily publications from across the world.
See the full list of The 100 Influential CEOs in Oncology in 2025 and stay tuned for other special category nominations.
